Krka, d. d. (LJSE:KRKG)

Market Cap	7.37B +45.3%
Revenue (ttm)	2.01B +5.7%
Net Income	398.80M +10.8%
EPS	13.02 +11.6%
Shares Out	30.46M
PE Ratio	18.58
Forward PE	18.37
Dividend	8.25 (3.41%)
Ex-Dividend Date	Jul 22, 2025

Volume	3,317
Average Volume	3,934
Open	243.00
Previous Close	242.00
Day's Range	242.00 - 243.00
52-Week Range	150.50 - 251.00
Beta	0.47
RSI	63.91
Earnings Date	Jan 29, 2026

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, oncology, pain relief, antiinfectives for systemic use, antidiabetics, and other products. It provides non-prescription prod...

• Industry: Pharmaceutical Preparations
• Founded: 1954
• Employees: 13,107
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: KRKG

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.